Investment analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of Onsemi in a note ...

Research analysts at Zacks Research increased their Q1 2025 earnings per share estimates for The PNC Financial Services Group ...

Two out of the three major U.S. indexes — the Nasdaq Composite and the S&P 500 have gained 0.68% and 0.52%, respectively, ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Boston ...

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & ...

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share. The drug developer posted revenue ...

Zacks Small Cap Research was hard at work in 2024 initiating analyst coverage on 40 companies. Each of our initiation reports provides a valuation, investment thesis and financial forecast model ...

Below we share with you three top-ranked mid-cap growth mutual funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).

Medpace expects full-year earnings to be $11.93 to $12.69 per share, with revenue in the range of $2.11 billion to $2.21 billion. This story was generated by Automated Insights ( ...